FD
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.874
Exchange
XNAS - Nasdaq
-39 %
Last period ROE
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also 4D Molecular
Company Analysis
FDMT valuation, rating, competitors, insights and company profile
Eyestock Rating
FDMT financial analysis by Eyestock methodology
Valuation
FDMT valuation using historical relative method
Statements
FDMT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
FDMT dividend yield and annual dividend
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
4D Molecular`s ROE for the last twelve months ended 2024-06-30 is -39 %
